• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Thawed Plasma in Emergency Department Expedites Transfusion and May Benefit Trauma Patients

March 22, 2013

Expedited transfusion of plasma to severely injured trauma patients presenting to emergency departments (ED) may reduce overall blood product use and mortality, according to a study published in the journal JAMA Surgery. Using a retrospective cohort analysis of 294 adult trauma patients admitted to a level I trauma center, researchers evaluated the impact of a new program which placed readily available thawed plasma in the ED emergency release blood refrigerator. Prior to the program, thawed plasma had been available to patients from a blood bank close to the ED. Patients who received thawed plasma from the ED refrigerator received plasma earlier than patients admitted before the program was implemented (43 vs. 89 minutes, p< 0.001). In addition, the new program was associated with reduced 24-hour use of RBCs, plasma, and platelets, and decreased odds of 30-day mortality. A prospective randomized study is needed to further understand the effects of early plasma transfusion.

References

1.     Radwan ZA, Bai Y, Matijevic N, Del Junco DJ, McCarthy JJ, Wade CE, Holcomb JB, Cotton BA. An emergency department thawed plasma protocol for severely injured patients. JAMA Surg 2013;148: 170-5.

2.    Hiatt JR. Stopping the bleeding: comment on “an emergency department thawed plasma protocol for severely injured patients”. JAMA Surg 2013;148: 175-6.

Filed Under

  • Coagulation & Plasma Transfusion
  • News

Recommended

  • New FDA Draft Guidance to Reduce Transfusion-Transmitted Malaria

  • Daprodustat is Noninferior to Erythropoiesis-Stimulating Agents for Patients with Chronic Kidney Disease Undergoing Dialysis

  • Weak HLA Antibody Levels Not Associated with Platelet Refractoriness

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley